Speakers | Kisaco Research

Speakers

The UPC Litigation Forum
20 January, 2025
Amsterdam, Beurs Van Berlage Centre
  • Author:

    Agathe Michel-De-Cazotte

    Partner
    Carpmaels & Ransford

    Agathe Michel-De-Cazotte

    Partner
    Carpmaels & Ransford
  • Author:

    Andreas Robinson

    Senior Counsel Intellectual Property & Litigation
    Amgen

    Andreas Robinson

    Senior Counsel Intellectual Property & Litigation
    Amgen
  • Author:

    Beat Weibel

    Chief IP Counsel
    Siemens

    Beat Weibel

    Chief IP Counsel
    Siemens
  • Author:

    Clemens Heusch

    Head of Global Disputes and Resolution
    Nokia

    Clemens Heusch

    Head of Global Disputes and Resolution
    Nokia
  • Author:

    Edger Brinkman

    Honourable Judge, Local Division Hague
    UPC

    Edger Brinkman

    Honourable Judge, Local Division Hague
    UPC
  • Author:

    Emily Bottle

    Leadership Committee
    ChIPs

    Emily Bottle

    Leadership Committee
    ChIPs
  • Author:

    Filip De Corte

    Head of IP
    Syngenta

    Filip De Corte is Head of Intellectual Property at Syngenta Crop Protection, leading patent attorneys based in Switzerland, the UK, the US, The Netherlands and China. Filip joined Syngenta on October 1, 2013. Until then, he held the position of Chief IP Counsel Europe at Cargill (2008 – 2013). Before joining Cargill in 2008, he worked in the Johnson & Johnson patent department, working in Beerse with Janssen Pharmaceutica (1991-2004), New Brunswick (2004-2007), and Brussels (2007-2008). Filip has a Ph.D. in organic chemistry, he is a qualified European Patent Attorney and passed the US patent bar exam. He has the qualification of European Patent Litigation from the University of Strasbourg. He also has an MBA of the Vlerick School of Management.  Filip taught patent law in Antwerp under the auspices of CEIPI (Université de Strasbourg) as well as at the University of Leuven in the IPR management course and is a lecturer in the CEIPI patent litigation course.

    Filip De Corte

    Head of IP
    Syngenta

    Filip De Corte is Head of Intellectual Property at Syngenta Crop Protection, leading patent attorneys based in Switzerland, the UK, the US, The Netherlands and China. Filip joined Syngenta on October 1, 2013. Until then, he held the position of Chief IP Counsel Europe at Cargill (2008 – 2013). Before joining Cargill in 2008, he worked in the Johnson & Johnson patent department, working in Beerse with Janssen Pharmaceutica (1991-2004), New Brunswick (2004-2007), and Brussels (2007-2008). Filip has a Ph.D. in organic chemistry, he is a qualified European Patent Attorney and passed the US patent bar exam. He has the qualification of European Patent Litigation from the University of Strasbourg. He also has an MBA of the Vlerick School of Management.  Filip taught patent law in Antwerp under the auspices of CEIPI (Université de Strasbourg) as well as at the University of Leuven in the IPR management course and is a lecturer in the CEIPI patent litigation course.

  • Author:

    Gaëlle Bourout

    Counsel
    Linklaters

    Gaëlle Bourout

    Counsel
    Linklaters
  • Author:

    Gabriele Mohsler

    VP Patent Development
    Ericsson

    Gabriele Mohsler

    VP Patent Development
    Ericsson
  • Author:

    Jiri Slavik

    Director of IP
    Adalvo

    Jiri Slavik

    Director of IP
    Adalvo
  • Author:

    Juliane Buchinski

    Lead IP Litigation Counsel
    ZTE

    Juliane Buchinski

    Lead IP Litigation Counsel
    ZTE
  • Author:

    Laila Beynon

    AD- Dispute Resolution
    Regeneron

    Laila Beynon is Director, Dispute Resolution at Regeneron, responsible for the strategic co-ordination of ex-US patent litigation. She has a PhD in Biochemistry/Molecular Biology, 10 years’ private practice experience in life sciences patent litigation at Herbert Smith Freehills LLP, and prior to her role at Regeneron headed up the Patent Litigation team at BAT. 

    Laila Beynon

    AD- Dispute Resolution
    Regeneron

    Laila Beynon is Director, Dispute Resolution at Regeneron, responsible for the strategic co-ordination of ex-US patent litigation. She has a PhD in Biochemistry/Molecular Biology, 10 years’ private practice experience in life sciences patent litigation at Herbert Smith Freehills LLP, and prior to her role at Regeneron headed up the Patent Litigation team at BAT. 

  • Author:

    Luca Pellicciari

    Partner
    Trevisan & Cuonzo

    Luca Pellicciari

    Partner
    Trevisan & Cuonzo
  • Author:

    Manuel Neetz

    Head of IP- Diagnostic Imaging
    Siemens Healthineers

    Manuel Neetz

    Head of IP- Diagnostic Imaging
    Siemens Healthineers
  • Author:

    Margot Kokke

    Honourable Judge, Local Division Hague
    UPC

    Margot Kokke

    Honourable Judge, Local Division Hague
    UPC
  • Author:

    Matthias Zigann

    Honourable Judge
    UPC Local Division, Munich

    Matthias Zigann

    Honourable Judge
    UPC Local Division, Munich
  • Author:

    Ronny Thomas

    Honourable Judge
    UPC Local Division, Dusseldorf

    Ronny Thomas

    Honourable Judge
    UPC Local Division, Dusseldorf
  • Author:

    Sara Burghart

    Senior Counsel- Patent Litigation
    BAT

    Sara Burghart

    Senior Counsel- Patent Litigation
    BAT
  • Author:

    Sean Alexander

    Head of IP Strategy
    Umicore

    Sean Alexander is a qualified European Patent Attorney as well as a Canadian and U.S. Patent Agent. He has worked in the IP field for many years and is currently the Head of IP Strategy (H&N) for Chr. Hansen in Denmark. Prior to joining Chr. Hansen, Sean headed the IP team at Elanco Inc. based in the Netherlands and was a Partner with Gowling WLG in Canada. Sean has been recognized as one of the world's leading IP strategists by IAM Magazine and is regularly praised for his pragmatic and commercially aware approach to IP.

    Sean Alexander

    Head of IP Strategy
    Umicore

    Sean Alexander is a qualified European Patent Attorney as well as a Canadian and U.S. Patent Agent. He has worked in the IP field for many years and is currently the Head of IP Strategy (H&N) for Chr. Hansen in Denmark. Prior to joining Chr. Hansen, Sean headed the IP team at Elanco Inc. based in the Netherlands and was a Partner with Gowling WLG in Canada. Sean has been recognized as one of the world's leading IP strategists by IAM Magazine and is regularly praised for his pragmatic and commercially aware approach to IP.

  • Author:

    Stefanie Kies

    Senior Director Intellectual Property
    Polpharma Biologics

    Stefanie Kies

    Senior Director Intellectual Property
    Polpharma Biologics
  • Author:

    Stefan Luginbuehl

    Head of Department European Legal Affairs
    European Patent Office (EPO)

    Stefan Luginbuehl, PhD, lawyer, is Head of the Department European Legal Affairs (Dep 5222) at the European Patent Office where he is dealing with a wide range of patent law and patent litigation related subjects, with emphasis on the implementation of the EU unitary patent package into the existing European patent system.

    He participated in several Diplomatic and Intergovernmental Conferences on the reform of the European patent system and the international litigation system. He is a lecturer in different universities and is the author and editor of several books and articles on patent procedure and patent litigation in Europe and China.

    Stefan Luginbuehl

    Head of Department European Legal Affairs
    European Patent Office (EPO)

    Stefan Luginbuehl, PhD, lawyer, is Head of the Department European Legal Affairs (Dep 5222) at the European Patent Office where he is dealing with a wide range of patent law and patent litigation related subjects, with emphasis on the implementation of the EU unitary patent package into the existing European patent system.

    He participated in several Diplomatic and Intergovernmental Conferences on the reform of the European patent system and the international litigation system. He is a lecturer in different universities and is the author and editor of several books and articles on patent procedure and patent litigation in Europe and China.

  • Author:

    Tess Waldron

    Leadership Committeee
    ChIPs

    Tess Waldron

    Leadership Committeee
    ChIPs
  • Author:

    Annika Lückemann

    Counsel
    Bird & Bird

    Annika Lückemann

    Counsel
    Bird & Bird
  • Author:

    Antje Brambrink

    Partner
    Finnegan

    Dr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. Our clients appreciate Antje’s deep understanding of the life sciences sector based on her dual qualification as a licensed dentist.

     

    As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court.

     

    In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC). She has extensive experience in the European coordination of multinational patent disputes.

     

    Prior to joining Finnegan, Antje practiced patent litigation for several years in the patent litigation teams of two international law firms seated in Germany. Antje’s medical and scientific background is of great benefit in advising clients from the life sciences sector. Renowned pharmaceutical, biotechnology and medical devices companies regularly seek her advice. She also advises in the field of renewable energies and in the enforcement of standard-essential patents.

    Antje Brambrink

    Partner
    Finnegan

    Dr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. Our clients appreciate Antje’s deep understanding of the life sciences sector based on her dual qualification as a licensed dentist.

     

    As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court.

     

    In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC). She has extensive experience in the European coordination of multinational patent disputes.

     

    Prior to joining Finnegan, Antje practiced patent litigation for several years in the patent litigation teams of two international law firms seated in Germany. Antje’s medical and scientific background is of great benefit in advising clients from the life sciences sector. Renowned pharmaceutical, biotechnology and medical devices companies regularly seek her advice. She also advises in the field of renewable energies and in the enforcement of standard-essential patents.